Jefferies Says No Changes to Ests on Amgen (AMGN) Amid Parsabiv CRL; Affirms at 'Buy'
Go back to Jefferies Says No Changes to Ests on Amgen (AMGN) Amid Parsabiv CRL; Affirms at 'Buy'| Amgen Inc (NASDAQ: AMGN) | Delayed: 353.23 +6.22 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $347.01 | 52 Week High | $176.85 | |||
| Open | $348.00 | 52 Week Low | $133.64 | |||
| Day High | $353.26 | P/E | 53.20 | |||
| Day Low | $346.00 | EPS | $6.64 | |||
| Volume | 963,639 | |||||

